Proteomic investigation of dermal fibroblasts isolated from affected and unaffected skin samples from patients with limited cutaneous systemic sclerosis: 2 distinct entities?

Journal of Rheumatology

Volumn 44, Issue 1, 2017, Pages 40-48

  Corallo, Claudio ^a   Santucci, Annalisa ^a   Bernardini, Giulia ^a   Figura, Natale ^a   Leoncini, Roberto ^a   Riolo, Giulia ^a   Montella, Antonio ^a   Chirico, Chiara ^a   Nuti, Ranuccio ^a   Giordano, Nicola ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; MESSENGER RNA; VIMENTIN;

ADULT; ARTICLE; CELL ISOLATION; CELL LYSATE; CELL METABOLISM; CONTROLLED STUDY; CYTOSKELETON; ENERGY METABOLISM; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMITED CUTANEOUS SYSTEMIC SCLEROSIS; MASS SPECTROMETRY; MIDDLE AGED; MYOFIBROBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; FIBROBLAST; LIMITED SCLERODERMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

CYTOSKELETON; ENERGY METABOLISM; FEMALE; FIBROBLASTS; HUMANS; MIDDLE AGED; PROTEOMICS; SCLERODERMA, LIMITED; SIGNAL TRANSDUCTION; SKIN;

EID: 85008226089     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.160736     Document Type: Article

References (42)

1. Denton CP. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med 2016;16:55-60.
2. Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65:2737-47.
3. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996;22:647-74.
4. Del Galdo F, Shaw MA, Jimenez SA. Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis. Am J Pathol 2010;177:1638-46.
5. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
6. Desbois AC, Cacoub P. Systemic sclerosis: An update in 2016. Autoimmun Rev 2016;15:417-26.
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
8. Bjellqvist B, Pasquali C, Ravier F, Sanchez JC, Hochstrasser D. A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. Electrophoresis 1993;14:1357-65.
9. Hochstrasser DF, Harrington MG, Hochstrasser AC, Miller MJ, Merril CR. Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem 1988;173:424-35.
10. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 1980;105:361-3.
11. Hochstrasser DF, Patchornik A, Merril CR. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 1988;173:412-23.
12. Hellman U, Wernstedt C, Gonez J, Heldin CH. Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal Biochem 1995;224:451-5.
13. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 2009;4:44-57.
14. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37:1-13.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
16. Aden N, Shiwen X, Aden D, Black C, Nuttall A, Denton CP, et al. Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology 2008;47:1754-60.
17. Davidson JM. Proteomic revelations. J Invest Dermatol 2014;134:2301-2.
18. Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V. Systemic sclerosis: Markers and targeted treatments. Acta Reumatol Port 2016;41:18-25.
19. Abraham DJ, Eckes B, Rajkumar V, Krieg T. New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma. Curr Rheumatol Rep 2007;9:136-43.
20. Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, et al. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005;280:36474-82.
21. Tomcik M, Palumbo-Zerr K, Zerr P, Avouac J, Dees C, Sumova B, et al. S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis. Ann Rheum Dis 2015;74:1748-55.
22. Cong L, Xia ZK, Yang RY. Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy. Arch Pharm 2014;347:609-15.
23. Stern EP, Denton CP. The pathogenesis of systemic sclerosis. Rheum Dis Clin North Am 2015;41:367-82.
24. Leask A. Matrix remodeling in systemic sclerosis. Semin Immunopathol 2015;37:559-63.
25. Gilbane AJ, Denton CP, Holmes AM. Scleroderma pathogenesis: A pivotal role for fibroblasts as effector cells. Arthritis Res Ther 2013;15:215.
26. Eckes B, Mauch C, Huppe G, Krieg T. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J 1996;315:549-54.
27. Challa AA, Stefanovic B. A novel role of vimentin filaments: Binding and stabilization of collagen mRNAs. Mol Cell Biol 2011;31:3773-89.
28. Nassar D, Letavernier E, Baud L, Aractingi S, Khosrotehrani K. Calpain activity is essential in skin wound healing and contributes to scar formation. PLoS One 2012;7:e37084.
29. Chan MW, Arora PD, Bozavikov P, McCulloch CA. FAK, PIP5KIgamma and gelsolin cooperatively mediate force-induced expression of alpha-smooth muscle actin. J Cell Sci 2009; 122:2769-81.
30. Feghali CA, Wright TM. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum 1999;42:1451-7.
31. Courtemanche N, Gifford SM, Simpson MA, Pollard TD, Koleske AJ. Abl2/Abl-related gene stabilizes actin filaments, stimulates actin branching by actin-related protein 2/3 complex, and promotes actin filament severing by cofilin. J Biol Chem 2015;290:4038-46.
32. Lai YZ, Chen J, Lin S. Effects of morphology of the microgroove titanium surface on expression of vinculin in human gingival fibroblasts. Shanghai Kou Qiang Yi Xue 2015;24:182-7.
33. Prunotto M, Bruschi M, Gunning P, Gabbiani G, Weibel F, Ghiggeri GM, et al. Stable incorporation of α-smooth muscle actin into stress fibers is dependent on specific tropomyosin isoforms. Cytoskeleton 2015;72:257-67.
34. Ingber DE. Cellular mechanotransduction: Putting all the pieces together again. FASEB J 2006;20:811-27.
35. Reich A, Meurer M, Eckes B, Friedrichs J, Muller DJ. Surface morphology and mechanical properties of fibroblasts from scleroderma patients. J Cell Mol Med 2009;13:1644-52.
36. Nho RS, Xia H, Kahm J, Kleidon J, Diebold D, Henke CA. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway. J Biol Chem 2005; 280:26630-9.
37. Bourji K, Meyer A, Chatelus E, Pincemail J, Pigatto E, Defraigne JO, et al. High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis. Free Radic Biol Med 2015;87:282-9.
38. Piera-Velazquez S, Makul A, Jimenez SA. Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: Regulation by transforming growth factor β. Arthritis Rheumatol 2015;67:2749-58.
39. Amico D, Spadoni T, Rovinelli M, Serafini M, D'Amico G, Campelli N, et al. Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2. Arthritis Res Ther 2015;17:68.
40. Sambo P, Amico D, Giacomelli R, Matucci-Cerinic M, Salsano F, Valentini G, et al. Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A pilot study. J Rheumatol 2001;28:2257-62.
41. Grygiel-Gorniak B, Puszczewicz M. Oxidative damage and antioxidative therapy in systemic sclerosis. Mediators Inflamm 2014;2014:389582.
42. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 2011;51:1289-301.